ANDROGEN REPLACEMENT THERAPY MARKET ANALYSIS

Androgen Replacement Therapy Market, By Product Type (Testosterone Creams/Gels, Testosterone Patches, Testosterone Injections, Testosterone Implants, and Testosterone Tablets/Capsules/Gums), By Active Ingredient (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jun 2023
Code : CMI3787
Pages :191
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Androgen Replacement Therapy Market: Key Developments

On June 1, 2023, Getlabs, Inc., a provider for at-home diagnostic collections, partnered with Fountain TRT, a provider of testosterone replacement therapy (TRT) for men, to offer convenient at-home hormone testing and treatment.

On April 3, 2023, the U.K. Department of Health and Social Care, announced the launch of a new scheme to expand access to cheaper Hormone Replacement Therapy (HRT) drugs. This initiative was introduced to cut cost burden for hormone replacement therapies in the U.K.

On May 10, 2023, FarmaKeio Pharmacy Network, a pharmaceutical outsourcing facility in the U.S., was granted a patent to produce testosterone and triamcinolone subcutaneous hormone pellets. The drug was introduced to provide a sustained release of testosterone and triamcinolone, allowing patients to enjoy the benefits of these hormones for extended periods of time.